Sleep disorders and quality of life in patients after kidney transplantation

Sleep and Quality of Life in Clinical Medicine

Volumn , Issue , 2008, Pages 401-409

  Molnar, Miklos Zsolt ^a   Mucsi, Istvan ^a   Novak, Marta ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

dialysis; insomnia; quality of life; restless legs syndrome; sleep apnea; Sleep disorders; survival; transplantation

Indexed keywords

EID: 84861489412     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-60327-343-5_42     Document Type: Chapter

References (107)

1. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, Held PJ and Port FK. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341 (23): 1725-30.
2. Valderrabano F, Jofre R and Lopez-Gomez JM. Quality of life in end-stage renal disease patients. Am J Kidney Dis 2001; 38 (3): 443-64.
3. Cameron JI, Whiteside C, Katz J and Devins GM. Differences in quality of life across renal replacement therapies: a metaanalytic comparison. Am J Kidney Dis 2000; 35 (4): 629-37.
4. Baines LS, Joseph JT and Jindal RM. Emotional issues after kidney transplantation: a prospective psychotherapeutic study. Clin Transplant 2002; 16 (6): 455-60.
5. Evans RW. Recombinant human erythropoietin and the quality of life of end-stage renal disease patients: a comparative analysis. Am J Kidney Dis 1991; 18 (4 Suppl 1): 62-70.
6. Matas AJ, Halbert RJ, Barr ML, Helderman JH, Hricik DE, Pirsch JD, Schenkel FA, Siegal BR, Liu H and Ferguson RM. Life satisfaction and adverse effects in renal transplant recipients: a longitudinal analysis. Clin Transplant 2002; 16 (2): 113-21.
7. Gudex CM. Health-related quality of life in endstage renal failure. Qual Life Res 1995; 4 (4): 359-66.
8. Pietrabissa A, Ciaramella A, Carmellini M, Massimetti G, Giulianotti PC, Ferrari M, Corradi I and Mosca F. Effect of kidney transplantation on quality of life measures. Transpl Int 1992; 5 Suppl 1: S708-10.
9. Jofre R, Lopez-Gomez JM, Moreno F, Sanz-Guajardo D and Valderrabano F. Changes in quality of life after renal transplantation. Am J Kidney Dis 1998; 32 (1): 93-100.
10. Fujisawa M, Ichikawa Y, Yoshiya K, Isotani S, Higuchi A, Nagano S, Arakawa S, Hamami G, Matsumoto O and Kamidono S. Assessment of health-related quality of life in renal transplant and hemodialysis patients using the SF-36 health survey. Urology 2000; 56 (2): 201-6.
11. Ware JE, Jr. and Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30 (6): 473-83.
12. Rebollo P, Ortega F, Baltar JM, Badia X, Alvarez-Ude F, Diaz-Corte C, Naves M, Navascues RA, Urena A and Alvarez-Grande J. Health related quality of life (HRQOL) of kidney transplanted patients: variables that influence it. Clin Transplant 2000; 14 (3): 199-207.
13. Novak M, Molnar MZ, Ambrus C, Kovacs AZ, Koczy A, Remport A, Szeifert L, Szentkiralyi A, Shapiro CM, Kopp MS and Mucsi I. Chronic insomnia in kidney transplant recipients. Am J Kidney Dis 2006; 47 (4): 655-65.
14. Molnar MZ, NovakM, Ambrus C, Kovacs A, Pap J, Remport A, Szeifert L and Mucsi I. Anemia in kidney transplanted patients. Clin Transplant 2005; 19 (6): 825-33.
15. Hays RD, Kallich JD, Mapes DL, Coons SJ and Carter WB. Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res 1994; 3 (5): 329-38.
16. Hays R, Kallich J, Mapes D, Coons S and Carter W. Kidney Disease Quality of Life Short Form (KDQOL-SFTM), Version 1.3: A Manual for Use and Scoring. Santa Monica, CA: Hays R, Kallich J, Mapes D, Coons S and Carter W 1997.
17. Barotfi S, Molnar MZ, Almasi C, Kovacs AZ, Remport A, Szeifert L, Szentkiralyi A, Vamos E, Zoller R, Eremenco S, NovakMandMucsi I. Validation of the Kidney Disease Quality of Life-Short Form questionnaire in kidney transplant patients. J Psychosom Res 2006; 60 (5): 495-504.
18. Lofaso F, Verschueren P, Rande JL, Harf A and Goldenberg F. Prevalence of sleep-disordered breathing in patients on a heart transplant waiting list. Chest 1994; 106 (6): 1689-94.
19. Brilakis ES, Olson EJ, McGregor CG and Olson LJ. Sleep apnea in heart transplant recipients: type, symptoms, risk factors, and response to nasal continuous positive airway pressure. J Heart Lung Transplant 2000; 19 (4): 330-6.
20. Villa M, Lage E, Quintana E, Cabezon S, Moran JE, Martinez A, Carmona C, Capote F, Ordonez A and Cisneros JM. Prevalence of sleep breathing disorders in outpatients on a heart transplant waiting list. Transpl Proc 2003; 35 (5): 1944-5.
21. Skobel E, Kaminski R, Breuer C, Topper R, Reffelmann T and Schwarz ER. [Remission of nocturnal pathological respiratory patterns after orthotopic heart transplantation. A case report and overview of current status of therapy]. Med Klin (Munich) 2000; 95 (12): 706-11.
22. Roebuck T, Solin P, Kaye DM, Bergin P, Bailey M and Naughton MT. Increased long-Term mortality in heart failure due to sleep apnoea is not yet proven. Eur Respir J 2004; 23 (5): 735-40.
23. Javaheri S, Abraham WT, Brown C, Nishiyama H, Giesting R and Wagoner LE. Prevalence of obstructive sleep apnoea and periodic limb movement in 45 subjects with heart transplantation. Eur Heart J 2004; 25 (3): 260-6.
24. Kaw R, Golish J, Ghamande S, Burgess R, Foldvary N and Walker E. Incremental risk of obstructive sleep apnea on cardiac surgical outcomes. J Cardiovasc Surg 2006; 47 (6): 683-9.
25. Kaw R, Michota F, Jaffer A, Ghamande S, Auckley D and Golish J. Unrecognized sleep apnea in the surgical patient: implications for the perioperative setting. Chest 2006; 129 (1): 198-205.
26. Gross JB, Bachenberg KL, Benumof JL, Caplan RA, Connis RT, Cote CJ, Nickinovich DG, Prachand V, Ward DS, Weaver EM, Ydens L and Yu S. Practice guidelines for the perioperative management of patients with obstructive sleep apnea: a report by the American Society of Anesthesiologists Task Force on Perioperative Management of patients with obstructive sleep apnea. Anesthesiology 2006; 104 (5): 1081-93; quiz 117-8.
27. Mansfield DR, Solin P, Roebuck T, Bergin P, Kaye DM and Naughton MT. The effect of successful heart transplant treatment of heart failure on central sleep apnea. Chest 2003; 124 (5): 1675-81.
28. Littlefield C, Abbey S, Fiducia D, Cardella C, Greig P, Levy G, Maurer J andWinton T. Quality of life following transplantation of the heart, liver, and lungs. Gen Hosp Psychiatry 1996; 18 (6 Suppl): 36S-47S.
29. Cohen L, Littlefield C, Kelly P, Maurer J and Abbey S. Predictors of quality of life and adjustment after lung transplantation. Chest 1998; 113 (3): 633-44.
30. Neuhaus P, McMaster P, Calne R, Pichlmayr R, Otto G, Williams R, Bismuth H and Groth C. Neurological complications in the European multicentre study of FK 506 and cyclosporin in primary liver transplantation. Transpl Int 1994; 7 Suppl 1: S27-31.
31. Kreitzer MJ, Gross CR, Ye X, Russas V and Treesak C. Longitudinal impact of mindfulness meditation on illness burden in solid-organ transplant recipients. Prog Transplant 2005; 15 (2): 166-72.
32. Iliescu EA, Coo H, McMurray MH, Meers CL, Quinn MM, Singer MA and Hopman WM. Quality of sleep and healthrelated quality of life in haemodialysis patients. Nephrol Dial Transplant 2003; 18 (1): 126-32.
33. Iliescu EA, Yeates KE and Holland DC. Quality of sleep in patients with chronic kidney disease. Nephrol Dial Transplant 2004; 19 (1): 95-9.
34. Parker KP. Sleep disturbances in dialysis patients. Sleep Med Rev 2003; 7 (2): 131-43.
35. Parker KP, Kutner NG, Bliwise DL, Bailey JL and Rye DB. Nocturnal sleep, daytime sleepiness, and quality of life in stable patients on hemodialysis. Health Qual Life Outcomes 2003; 1 (1): 68.
36. Sabbatini M, Minale B, Crispo A, Pisani A, Ragosta A, Esposito R, Cesaro A, Cianciaruso B and Andreucci VE. Insomnia in maintenance haemodialysis patients. Nephrol Dial Transplant 2002; 17 (5): 852-6.
37. Mucsi I, Molnar MZ, Rethelyi J, Vamos E, Csepanyi G, Tompa G, Barotfi S, Marton A and Novak M. Sleep disorders and illness intrusiveness in patients on chronic dialysis. Nephrol Dial Transplant 2004; 19 (7): 1815-22.
38. Walsh JK. Clinical and socioeconomic correlates of insomnia. J Clin Psychiatry 2004; 65 Suppl 8: 13-9.
39. Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 2002; 6 (2): 97-111.
40. Hatoum HT, Kong SX, Kania CM, Wong JM and Mendelson WB. Insomnia, health-related quality of life and healthcare resource consumption. A study of managed-care organisation enrollees. Pharmacoeconomics 1998; 14 (6): 629-37.
41. Chevalier H, Los F, Boichut D, Bianchi M, Nutt DJ, Hajak G, Hetta J, Hoffmann G and Crowe C. Evaluation of severe insomnia in the general population: results of a European multinational survey. J Psychopharmacol 1999; 13 (4 Suppl 1): S21-4.
42. Mallon L, Broman JE and Hetta J. Relationship between insomnia, depression, and mortality: a 12-year follow-up of older adults in the community. Int Psychogeriatr 2000; 12 (3): 295-306.
43. Mallon L, Broman JE and Hetta J. Sleep complaints predict coronary artery disease mortality in males: a 12-year follow-up study of a middle-Aged Swedish population. J Intern Med 2002; 251 (3): 207-16.
44. Novak M, Mucsi I, Shapiro CM, Rethelyi J and Kopp MS. Increased utilization of health services by insomniacs-An epidemiological perspective. J Psychosom Res 2004; 56 (5): 527-36.
45. Ohayon M. Epidemiological study on insomnia in the general population. Sleep 1996; 19 (3 Suppl): S7-15.
46. Ohayon MM and Roberts RE. Comparability of sleep disorders diagnoses using DSM-IV and ICSD classifications with adolescents. Sleep 2001; 24 (8): 920-5.
47. Ohayon MM and Roth T. What are the contributing factors for insomnia in the general population? J Psychosom Res 2001; 51 (6): 745-55.
48. Ohayon MM, Guilleminault C, Paiva T, Priest RG, Rapoport DM, Sagales T, Smirne S and Zulley J. An international study on sleep disorders in the general population: methodological aspects of the use of the Sleep-EVAL system. Sleep 1997; 20 (12): 1086-92.
49. Soldatos CR, Dikeos DG and Paparrigopoulos TJ. The diagnostic validity of the Athens Insomnia Scale. J Psychosom Res 2003; 55 (3): 263-7.
50. Soldatos CR, Dikeos DG and Paparrigopoulos TJ. Athens Insomnia Scale: validation of an instrument based on ICD-10 criteria. J Psychosom Res 2000; 48 (6): 555-60.
51. Sabbatini M, Crispo A, Pisani A, Gallo R, Cianciaruso B, Fuiano G, Federico S and Andreucci VE. Sleep quality in renal transplant patients: a never investigated problem. Nephrol Dial Transplant 2005; 20 (1): 194-8.
52. Eryilmaz MM, Ozdemir C, Yurtman F, Cilli A and Karaman T. Quality of sleep and quality of life in renal transplantation patients. Transplant Proc 2005; 37 (5): 2072-6.
53. Redline S and Strohl KP. Recognition and consequences of obstructive sleep apnea hypopnea syndrome. Clin Chest Med 1998; 19 (1): 1-19.
54. Young T, Palta M, Dempsey J, Skatrud J, Weber S and Badr S. The occurrence of sleep-disordered breathing among middleaged adults. N Engl J Med 1993; 328 (17): 1230-5.
55. Baldwin CM, Griffith KA, Nieto FJ, O'Connor GT, Walsleben JA and Redline S. The association of sleep-disordered breathing and sleep symptoms with quality of life in the Sleep Heart Health Study. Sleep 2001; 24 (1): 96-105.
56. de Oliveira Rodrigues CJ, Marson O, Tufic S, Kohlmann O, Jr., Guimaraes SM, Togeiro P, Ribeiro AB and Tavares A. Relationship among end-stage renal disease, hypertension, and sleep apnea in nondiabetic dialysis patients. Am J Hypertens 2005; 18 (2 Pt 1): 152-7.
57. Hui DS, Wong TY, Li TS, Ko FW, Choy DK, Szeto CC, Lui SF and Li PK. Prevalence of sleep disturbances in Chinese patients with end stage renal failure on maintenance hemodialysis. Med Sci Monit 2002; 8 (5): CR331-6.
58. Chen WC, Lim PS,Wu WC, Chiu HC, Chen CH, Kuo HY, Tsai TW, Chien PI, Su YJ, Su YL, Hung SH and Woods HF. Sleep behavior disorders in a large cohort of chinese (Taiwanese) patients maintained by long-Term hemodialysis. Am J Kidney Dis 2006; 48 (2): 277-84.
59. Hui DS, Wong TY, Ko FW, Li TS, Choy DK, Wong KK, Szeto CC, Lui SF and Li PK. Prevalence of sleep disturbances in chinese patients with end-stage renal failure on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 2000; 36 (4): 783-8.
60. Wadhwa NK, Seliger M, Greenberg HE, Bergofsky E and Mendelson WB. Sleep related respiratory disorders in end-stage renal disease patients on peritoneal dialysis. Perit Dial Int 1992; 12 (1): 51-6.
61. Merlino G, Piani A, Dolso P, Adorati M, Cancelli I, Valente M and Gigli GL. Sleep disorders in patients with end-stage renal disease undergoing dialysis therapy. Nephrol Dial Transplant 2006; 21 (1): 184-90.
62. Walker S, Fine A and Kryger MH. Sleep complaints are common in a dialysis unit.AmJKidney Dis 1995; 26 (5):751-6.
63. Markou N, Kanakaki M, Myrianthefs P, Hadjiyanakos D, Vlassopoulos D, Damianos A, Siamopoulos K, Vasiliou M and Konstantopoulos S. Sleep-disordered breathing in nondialyzed patients with chronic renal failure. Lung 2006; 184 (1): 43-9.
64. Hanly PJ and Pierratos A. Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. N Engl J Med 2001; 344 (2): 102-7.
65. Langevin B, Fouque D, Leger P and Robert D. Sleep apnea syndrome and end-stage renal disease. Cure after renal transplantation. Chest 1993; 103 (5): 1330-5.
66. Auckley DH, Schmidt-Nowara W and Brown LK. Reversal of sleep apnea hypopnea syndrome in end-stage renal disease after kidney transplantation. Am J Kidney Dis 1999; 34 (4): 739-44.
67. Koczy A, Molnar M, Vamos E, Kovacs A, Szentkiralyi A, Szeifert L, Zoller R, Dunai A, Mucsi I and Novak M. Obstructive sleep apnea syndrome is independently associated with worse quality of life in transplanted patients. QRL J 2006; A-68, Abstract 1173.
68. McNicholas WT and Bonsignore MR. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 2007; 29 (1): 156-78.
69. Zoccali C, Mallamaci F and Tripepi G. Nocturnal hypoxemia predicts incident cardiovascular complications in dialysis patients. J Am Soc Nephrol 2002; 13 (3): 729-33.
70. Yaggi H and Mohsenin V. Obstructive sleep apnoea and stroke. Lancet Neurol 2004; 3 (6): 333-42.
71. Van Meerhaeghe A, Moscariello A and Velkeniers B. Obstructive sleep apnoea-hypopnoea syndrome and arterial hypertension. Acta Cardiol 2006; 61 (1): 95-102.
72. Reichmuth KJ, Austin D, Skatrud JB and Young T. Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med 2005; 172 (12): 1590-5.
73. Arzt M and Bradley TD. Treatment of sleep apnea in heart failure. Am J Respir Crit Care Med 2006; 173 (12): 1300-8.
74. Mehra R, Benjamin EJ, Shahar E, Gottlieb DJ, Nawabit R, Kirchner HL, Sahadevan J and Redline S. Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med 2006; 173 (8): 910-6.
75. Vgontzas AN, Bixler EO and Chrousos GP. Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 2005; 9 (3): 211-24.
76. Kasiske BL. Risk factors for accelerated atherosclerosis in renal transplant recipients. Am J Med 1988; 84 (6): 985-92.
77. Lindholm A, Albrechtsen D, Frodin L, Tufveson G, Persson NH and Lundgren G. Ischemic heart disease-major cause of death and graft loss after renal transplantation in Scandinavia. Transplantation 1995; 60 (5): 451-7.
78. Walters AS. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord 1995; 10 (5): 634-42.
79. Allen RP, Picchietti D, HeningWA, Trenkwalder C,Walters AS and Montplaisir J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003; 4 (2): 101-19.
80. Earley CJ, Heckler D and Allen RP. The treatment of restless legs syndrome with intravenous iron dextran. Sleep Med 2004; 5 (3): 231-5.
81. Allen RP and Earley CJ. Restless legs syndrome: a review of clinical and pathophysiologic features. J Clin Neurophysiol 2001; 18 (2): 128-47.
82. Stiasny K OW, Trenkwalder C. Clinical symptomatology and treatment of restless legs syndrome and periodic limb movement disorder. Sleep Med Rev 2002; 6 (4): 253-65.
83. Nichols DA, Allen RP, Grauke JH, Brown JB, Rice ML, Hyde PR, Dement WC and Kushida CA. Restless legs syndrome symptoms in primary care: a prevalence study. Arch Intern Med 2003; 163 (19): 2323-9.
84. Tan EK, Seah A, See SJ, Lim E, Wong MC and Koh KK. Restless legs syndrome in an Asian population: a study in Singapore. Mov Disord 2001; 16 (3): 577-9.
85. Lavigne GJ and Montplaisir JY. Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep 1994; 17 (8): 739-43.
86. Phillips B, Young T, Finn L, Asher K, HeningWA and Purvis C. Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000; 160 (14): 2137-41.
87. Berger K, Luedemann J, Trenkwalder C, John U and Kessler C. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med 2004; 164 (2): 196-202.
88. Benz RL, Pressman MR, Hovick ET and Peterson DD. A preliminary study of the effects of correction of anemia with recombinant human erythropoietin therapy on sleep, sleep disorders, and daytime sleepiness in hemodialysis patients (The SLEEPO study). Am J Kidney Dis 1999; 34 (6): 1089-95.
89. O'Keeffe ST, Gavin K and Lavan JN. Iron status and restless legs syndrome in the elderly. Age Ageing 1994; 23 (3): 200-3.
90. Sloand JA, Shelly MA, Feigin A, Bernstein P and Monk RD. A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome. Am J Kidney Dis 2004; 43 (4): 663-70.
91. Winkelman JW, Chertow GM and Lazarus JM. Restless legs syndrome in end-stage renal disease. Am J Kidney Dis 1996; 28 (3): 372-8.
92. Takaki J, Nishi T, Nangaku M, Shimoyama H, Inada T, Matsuyama N, Kumano H and Kuboki T. Clinical and psychological aspects of restless legs syndrome in uremic patients on hemodialysis. Am J Kidney Dis 2003; 41 (4): 833-9.
93. Goffredo Filho GS, Gorini CC, Purysko AS, Silva HC and Elias IE. Restless legs syndrome in patients on chronic hemodialysis in a Brazilian city: frequency, biochemical findings and comorbidities. Arq Neuropsiquiatr 2003; 61 (3B): 723-7.
94. Unruh ML, Levey AS, D'Ambrosio C, Fink NE, Powe NR and Meyer KB. Restless legs symptoms among incident dialysis patients: association with lower quality of life and shorter survival. Am J Kidney Dis 2004; 43 (5): 900-9.
95. Gigli GL, Adorati M, Dolso P, Piani A, Valente M, Brotini S and Budai R. Restless legs syndrome in end-stage renal disease. Sleep Med 2004; 5 (3): 309-15.
96. Molnar MZ, Novak M, Ambrus C, Szeifert L, Kovacs A, Pap J, Remport A and Mucsi I. Restless Legs Syndrome in patients after renal transplantation. Am J Kidney Dis 2005; 45 (2): 388-96.
97. Winkelmann J, Stautner A, Samtleben W and Trenkwalder C. Long-Term course of restless legs syndrome in dialysis patients after kidney transplantation. Mov Disord 2002; 17 (5): 1072-6.
98. Krueger JM and Karnovsky ML. Sleep and the immune response. Ann N Y Acad Sci 1987; 496 510-6.
99. Moldofsky H, Lue FA, Davidson JR and Gorczynski R. Effects of sleep deprivation on human immune functions. FASEB J 1989; 3 (8): 1972-7.
100. Toth LA, Tolley EA and Krueger JM. Sleep as a prognostic indicator during infectious disease in rabbits. Proc Soc Exp Biol Med 1993; 203 (2): 179-92.
101. Rostand SG, Kirk KA and Rutsky EA. Relationship of coronary risk factors to hemodialysis-Associated ischemic heart disease. Kidney Int 1982; 22 (3): 304-8.
102. Rosansky SJ, Menachery SJ, Whittman D and Rosenberg JC. The relationship between sleep deprivation and the nocturnal decline of blood pressure. Am J Hypertens 1996; 9 (11): 1136-8.
103. Foley RN, Parfrey PS, Harnett JD, Kent GM,Martin CJ,Murray DC and Barre PE. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995; 47 (1): 186-92.
104. Winkelman JW, Finn L and Young T. Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort. Sleep Med 2006; 7(7): 545-2.
105. Ulfberg J, Nystrom B, Carter N and Edling C. Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms. Mov Disord 2001; 16 (6): 1159-63.
106. Ayas NT, White DP, Manson JE, Stampfer MJ, Speizer FE, Malhotra A and Hu FB. A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med 2003; 163 (2): 205-9.
107. Benz RL, Pressman MR, Hovick ET and Peterson DD. Potential novel predictors of mortality in end-stage renal disease patients with sleep disorders. Am J Kidney Dis 2000; 35 (6): 1052-60.